Breaking News

Olopatadine reduces burning sensation and itch in some tacrolimus-treated atopic dermatitis patients

Olopatadine reduces burning sensation and itch in some tacrolimus-treated atopic dermatitis patients

 
 

The transient burning sensation and stinging itch caused by tacrolimus ointment in atopic dermatitis (AD) patients can be distressing, especially in those with severe lesions. Although not fully elucidated, neuropeptide release at the application site may underlie these phenomena. Olopatadine is a second generation antihistamine with efficacy in allergic disorders; it may also decrease neuropeptide release at inflammatory sites. It reduced application site burning and pruritus in some AD patients (Kawashima, M. and Takahashi, T. 17th Congr Eur Acad Dermatol Venereol (EADV) (Sept. 17-21, Paris) 2008, Abst. FP0076).

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list